CEPP regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:Cyclophosphamide/Etoposide/Prednisone/Procarbazine
Overview
CEPP regimen refers to a regimen consisting of cyclophosphamide, etoposide, procarbazine and prednisone used to treat atypical presentation of Hodgkin lymphoma with severe abnormal liver function.[1]
Regimen
Ccyclophosphamide
Eetoposide
Pprocarbazine
Pprednisone
Indications
- Hodgkin lymphoma with severe abnormal liver function.[1]
References
- ↑ 1.0 1.1 Thakar K, Novero A, Das A, Lisinschi A, Mehta B, Ahmed T; et al. (2014). “CEPP regimen (cyclophosphamide, etoposide, procarbazine and prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function”. Biomark Res. 2: 12. doi:10.1186/2050-7771-2-12. PMC 4078319. PMID 24991411.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
